 | • レポートコード：MMG23DC12396 • 出版社/出版日：Market Monitor Global / 2023年12月 ※2025年版があります。お問い合わせください。 • レポート形態：英語、PDF、65ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療 |
| Single User（1名様閲覧用） | ￥471,250 (USD3,250) | ▷ お問い合わせ |
| Multi User（20名様閲覧用） | ￥612,625 (USD4,225) | ▷ お問い合わせ |
| Enterprise User（閲覧人数制限なし） | ￥706,875 (USD4,875) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査レポートは次の情報を含め、世界の間葉系幹細胞（MSC）療法市場規模と予測を収録しています。・世界の間葉系幹細胞（MSC）療法市場：売上、2018年-2023年、2024年-2029年 ・世界の間葉系幹細胞（MSC）療法市場：販売量、2018年-2023年、2024年-2029年 ・世界のトップ5企業、2022年 世界の間葉系幹細胞（MSC）療法市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「静脈内（IV）」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。 間葉系幹細胞（MSC）療法のグローバル主要企業は、TotiCell、 Celltex、 InGeneron、 Stempeutics Bangalore、 PuREC、 Corestem、 Sartorius、 StemcellX、 Cynata、 Amniotic、 Nuwacellなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。 MARKET MONITOR GLOBAL（MMG）は、間葉系幹細胞（MSC）療法のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。 【セグメント別市場分析】 世界の間葉系幹細胞（MSC）療法市場：タイプ別、2018年-2023年、2024年-2029年 世界の間葉系幹細胞（MSC）療法市場：タイプ別市場シェア、2022年 ・静脈内（IV）、経鼻（IN）、関節内（IA）、その他 世界の間葉系幹細胞（MSC）療法市場：用途別、2018年-2023年、2024年-2029年 世界の間葉系幹細胞（MSC）療法市場：用途別市場シェア、2022年 ・病院、診療所、研究所、その他 世界の間葉系幹細胞（MSC）療法市場：地域・国別、2018年-2023年、2024年-2029年 世界の間葉系幹細胞（MSC）療法市場：地域別市場シェア、2022年 ・北米：アメリカ、カナダ、メキシコ ・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア ・アジア：中国、日本、韓国、東南アジア、インド ・南米：ブラジル、アルゼンチン ・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE 【競合分析】 また、当レポートは主要な市場参加者の分析を提供します。 ・主要企業における間葉系幹細胞（MSC）療法のグローバル売上、2018年-2023年 ・主要企業における間葉系幹細胞（MSC）療法のグローバル売上シェア、2022年 ・主要企業における間葉系幹細胞（MSC）療法のグローバル販売量、2018年-2023年 ・主要企業における間葉系幹細胞（MSC）療法のグローバル販売量シェア、2022年 さらに、当レポートは主要企業のプロファイルを提示します。 TotiCell、 Celltex、 InGeneron、 Stempeutics Bangalore、 PuREC、 Corestem、 Sartorius、 StemcellX、 Cynata、 Amniotic、 Nuwacell ************************************************************* ・調査・分析レポートの概要 間葉系幹細胞（MSC）療法市場の定義 市場セグメント 世界の間葉系幹細胞（MSC）療法市場概要 当レポートの特徴・ベネフィット 調査手法と情報源 ・世界の間葉系幹細胞（MSC）療法市場規模 世界の間葉系幹細胞（MSC）療法市場規模：2022年 VS 2029年 世界の間葉系幹細胞（MSC）療法市場規模と予測 2018年-2029年 ・競争状況 グローバルトップ企業 売上ベースでのグローバルトップ企業 企業別グローバルでの間葉系幹細胞（MSC）療法の売上 グローバルトップ3およびトップ5企業、2022年売上ベース グローバル企業の間葉系幹細胞（MSC）療法製品タイプ グローバルにおけるティア1、ティア2、ティア3企業 ・タイプ別市場分析 タイプ区分：静脈内（IV）、経鼻（IN）、関節内（IA）、その他 間葉系幹細胞（MSC）療法のタイプ別グローバル売上・予測 ・用途別市場分析 用途区分：病院、診療所、研究所、その他 間葉系幹細胞（MSC）療法の用途別グローバル売上・予測 ・地域別市場分析 地域別間葉系幹細胞（MSC）療法市場規模 2022年と2029年 地域別間葉系幹細胞（MSC）療法売上・予測 北米市場：アメリカ、カナダ、メキシコ ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア アジア市場：中国、日本、韓国、東南アジア、インド 南米市場：ブラジル、アルゼンチン 中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE ・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど） TotiCell、 Celltex、 InGeneron、 Stempeutics Bangalore、 PuREC、 Corestem、 Sartorius、 StemcellX、 Cynata、 Amniotic、 Nuwacell ... |
This research report provides a comprehensive analysis of the Mesenchymal Stem Cell (MSC) Therapy market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Mesenchymal Stem Cell (MSC) Therapy market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Mesenchymal Stem Cell (MSC) Therapy, challenges faced by the industry, and potential opportunities for market players.
The global Mesenchymal Stem Cell (MSC) Therapy market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Mesenchymal Stem Cell (MSC) Therapy market presents opportunities for various stakeholders, including Hospital, Clinic. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Mesenchymal Stem Cell (MSC) Therapy market. Additionally, the growing consumer demand present avenues for market expansion.
The global Mesenchymal Stem Cell (MSC) Therapy market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Key Features:
The research report on the Mesenchymal Stem Cell (MSC) Therapy market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Mesenchymal Stem Cell (MSC) Therapy market.
Market Overview: The report provides a comprehensive overview of the Mesenchymal Stem Cell (MSC) Therapy market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Intravenous (IV), Intranasal (IN)), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Mesenchymal Stem Cell (MSC) Therapy market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Mesenchymal Stem Cell (MSC) Therapy market’s trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Mesenchymal Stem Cell (MSC) Therapy market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Mesenchymal Stem Cell (MSC) Therapy market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Mesenchymal Stem Cell (MSC) Therapy market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Mesenchymal Stem Cell (MSC) Therapy market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Mesenchymal Stem Cell (MSC) Therapy, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Mesenchymal Stem Cell (MSC) Therapy market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Mesenchymal Stem Cell (MSC) Therapy market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Intravenous (IV)
Intranasal (IN)
Intraarticular (IA)
Others
Market segment by Application
Hospital
Clinic
Research Institute
Others
Global Mesenchymal Stem Cell (MSC) Therapy Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
TotiCell
Celltex
InGeneron
Stempeutics Bangalore
PuREC
Corestem
Sartorius
StemcellX
Cynata
Amniotic
Nuwacell
Outline of Major Chapters:
Chapter 1: Introduces the definition of Mesenchymal Stem Cell (MSC) Therapy, market overview.
Chapter 2: Global Mesenchymal Stem Cell (MSC) Therapy market size in revenue.
Chapter 3: Detailed analysis of Mesenchymal Stem Cell (MSC) Therapy company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Mesenchymal Stem Cell (MSC) Therapy in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
1 Introduction to Research & Analysis Reports
1.1 Mesenchymal Stem Cell (MSC) Therapy Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Mesenchymal Stem Cell (MSC) Therapy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Mesenchymal Stem Cell (MSC) Therapy Overall Market Size
2.1 Global Mesenchymal Stem Cell (MSC) Therapy Market Size: 2022 VS 2029
2.2 Global Mesenchymal Stem Cell (MSC) Therapy Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Mesenchymal Stem Cell (MSC) Therapy Players in Global Market
3.2 Top Global Mesenchymal Stem Cell (MSC) Therapy Companies Ranked by Revenue
3.3 Global Mesenchymal Stem Cell (MSC) Therapy Revenue by Companies
3.4 Top 3 and Top 5 Mesenchymal Stem Cell (MSC) Therapy Companies in Global Market, by Revenue in 2022
3.5 Global Companies Mesenchymal Stem Cell (MSC) Therapy Product Type
3.6 Tier 1, Tier 2 and Tier 3 Mesenchymal Stem Cell (MSC) Therapy Players in Global Market
3.6.1 List of Global Tier 1 Mesenchymal Stem Cell (MSC) Therapy Companies
3.6.2 List of Global Tier 2 and Tier 3 Mesenchymal Stem Cell (MSC) Therapy Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type – Global Mesenchymal Stem Cell (MSC) Therapy Market Size Markets, 2022 & 2029
4.1.2 Intravenous (IV)
4.1.3 Intranasal (IN)
4.1.4 Intraarticular (IA)
4.1.5 Others
4.2 By Type – Global Mesenchymal Stem Cell (MSC) Therapy Revenue & Forecasts
4.2.1 By Type – Global Mesenchymal Stem Cell (MSC) Therapy Revenue, 2018-2023
4.2.2 By Type – Global Mesenchymal Stem Cell (MSC) Therapy Revenue, 2024-2029
4.2.3 By Type – Global Mesenchymal Stem Cell (MSC) Therapy Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Mesenchymal Stem Cell (MSC) Therapy Market Size, 2022 & 2029
5.1.2 Hospital
5.1.3 Clinic
5.1.4 Research Institute
5.1.5 Others
5.2 By Application – Global Mesenchymal Stem Cell (MSC) Therapy Revenue & Forecasts
5.2.1 By Application – Global Mesenchymal Stem Cell (MSC) Therapy Revenue, 2018-2023
5.2.2 By Application – Global Mesenchymal Stem Cell (MSC) Therapy Revenue, 2024-2029
5.2.3 By Application – Global Mesenchymal Stem Cell (MSC) Therapy Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region – Global Mesenchymal Stem Cell (MSC) Therapy Market Size, 2022 & 2029
6.2 By Region – Global Mesenchymal Stem Cell (MSC) Therapy Revenue & Forecasts
6.2.1 By Region – Global Mesenchymal Stem Cell (MSC) Therapy Revenue, 2018-2023
6.2.2 By Region – Global Mesenchymal Stem Cell (MSC) Therapy Revenue, 2024-2029
6.2.3 By Region – Global Mesenchymal Stem Cell (MSC) Therapy Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country – North America Mesenchymal Stem Cell (MSC) Therapy Revenue, 2018-2029
6.3.2 US Mesenchymal Stem Cell (MSC) Therapy Market Size, 2018-2029
6.3.3 Canada Mesenchymal Stem Cell (MSC) Therapy Market Size, 2018-2029
6.3.4 Mexico Mesenchymal Stem Cell (MSC) Therapy Market Size, 2018-2029
6.4 Europe
6.4.1 By Country – Europe Mesenchymal Stem Cell (MSC) Therapy Revenue, 2018-2029
6.4.2 Germany Mesenchymal Stem Cell (MSC) Therapy Market Size, 2018-2029
6.4.3 France Mesenchymal Stem Cell (MSC) Therapy Market Size, 2018-2029
6.4.4 U.K. Mesenchymal Stem Cell (MSC) Therapy Market Size, 2018-2029
6.4.5 Italy Mesenchymal Stem Cell (MSC) Therapy Market Size, 2018-2029
6.4.6 Russia Mesenchymal Stem Cell (MSC) Therapy Market Size, 2018-2029
6.4.7 Nordic Countries Mesenchymal Stem Cell (MSC) Therapy Market Size, 2018-2029
6.4.8 Benelux Mesenchymal Stem Cell (MSC) Therapy Market Size, 2018-2029
6.5 Asia
6.5.1 By Region – Asia Mesenchymal Stem Cell (MSC) Therapy Revenue, 2018-2029
6.5.2 China Mesenchymal Stem Cell (MSC) Therapy Market Size, 2018-2029
6.5.3 Japan Mesenchymal Stem Cell (MSC) Therapy Market Size, 2018-2029
6.5.4 South Korea Mesenchymal Stem Cell (MSC) Therapy Market Size, 2018-2029
6.5.5 Southeast Asia Mesenchymal Stem Cell (MSC) Therapy Market Size, 2018-2029
6.5.6 India Mesenchymal Stem Cell (MSC) Therapy Market Size, 2018-2029
6.6 South America
6.6.1 By Country – South America Mesenchymal Stem Cell (MSC) Therapy Revenue, 2018-2029
6.6.2 Brazil Mesenchymal Stem Cell (MSC) Therapy Market Size, 2018-2029
6.6.3 Argentina Mesenchymal Stem Cell (MSC) Therapy Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country – Middle East & Africa Mesenchymal Stem Cell (MSC) Therapy Revenue, 2018-2029
6.7.2 Turkey Mesenchymal Stem Cell (MSC) Therapy Market Size, 2018-2029
6.7.3 Israel Mesenchymal Stem Cell (MSC) Therapy Market Size, 2018-2029
6.7.4 Saudi Arabia Mesenchymal Stem Cell (MSC) Therapy Market Size, 2018-2029
6.7.5 UAE Mesenchymal Stem Cell (MSC) Therapy Market Size, 2018-2029
7 Mesenchymal Stem Cell (MSC) Therapy Companies Profiles
7.1 TotiCell
7.1.1 TotiCell Company Summary
7.1.2 TotiCell Business Overview
7.1.3 TotiCell Mesenchymal Stem Cell (MSC) Therapy Major Product Offerings
7.1.4 TotiCell Mesenchymal Stem Cell (MSC) Therapy Revenue in Global Market (2018-2023)
7.1.5 TotiCell Key News & Latest Developments
7.2 Celltex
7.2.1 Celltex Company Summary
7.2.2 Celltex Business Overview
7.2.3 Celltex Mesenchymal Stem Cell (MSC) Therapy Major Product Offerings
7.2.4 Celltex Mesenchymal Stem Cell (MSC) Therapy Revenue in Global Market (2018-2023)
7.2.5 Celltex Key News & Latest Developments
7.3 InGeneron
7.3.1 InGeneron Company Summary
7.3.2 InGeneron Business Overview
7.3.3 InGeneron Mesenchymal Stem Cell (MSC) Therapy Major Product Offerings
7.3.4 InGeneron Mesenchymal Stem Cell (MSC) Therapy Revenue in Global Market (2018-2023)
7.3.5 InGeneron Key News & Latest Developments
7.4 Stempeutics Bangalore
7.4.1 Stempeutics Bangalore Company Summary
7.4.2 Stempeutics Bangalore Business Overview
7.4.3 Stempeutics Bangalore Mesenchymal Stem Cell (MSC) Therapy Major Product Offerings
7.4.4 Stempeutics Bangalore Mesenchymal Stem Cell (MSC) Therapy Revenue in Global Market (2018-2023)
7.4.5 Stempeutics Bangalore Key News & Latest Developments
7.5 PuREC
7.5.1 PuREC Company Summary
7.5.2 PuREC Business Overview
7.5.3 PuREC Mesenchymal Stem Cell (MSC) Therapy Major Product Offerings
7.5.4 PuREC Mesenchymal Stem Cell (MSC) Therapy Revenue in Global Market (2018-2023)
7.5.5 PuREC Key News & Latest Developments
7.6 Corestem
7.6.1 Corestem Company Summary
7.6.2 Corestem Business Overview
7.6.3 Corestem Mesenchymal Stem Cell (MSC) Therapy Major Product Offerings
7.6.4 Corestem Mesenchymal Stem Cell (MSC) Therapy Revenue in Global Market (2018-2023)
7.6.5 Corestem Key News & Latest Developments
7.7 Sartorius
7.7.1 Sartorius Company Summary
7.7.2 Sartorius Business Overview
7.7.3 Sartorius Mesenchymal Stem Cell (MSC) Therapy Major Product Offerings
7.7.4 Sartorius Mesenchymal Stem Cell (MSC) Therapy Revenue in Global Market (2018-2023)
7.7.5 Sartorius Key News & Latest Developments
7.8 StemcellX
7.8.1 StemcellX Company Summary
7.8.2 StemcellX Business Overview
7.8.3 StemcellX Mesenchymal Stem Cell (MSC) Therapy Major Product Offerings
7.8.4 StemcellX Mesenchymal Stem Cell (MSC) Therapy Revenue in Global Market (2018-2023)
7.8.5 StemcellX Key News & Latest Developments
7.9 Cynata
7.9.1 Cynata Company Summary
7.9.2 Cynata Business Overview
7.9.3 Cynata Mesenchymal Stem Cell (MSC) Therapy Major Product Offerings
7.9.4 Cynata Mesenchymal Stem Cell (MSC) Therapy Revenue in Global Market (2018-2023)
7.9.5 Cynata Key News & Latest Developments
7.10 Amniotic
7.10.1 Amniotic Company Summary
7.10.2 Amniotic Business Overview
7.10.3 Amniotic Mesenchymal Stem Cell (MSC) Therapy Major Product Offerings
7.10.4 Amniotic Mesenchymal Stem Cell (MSC) Therapy Revenue in Global Market (2018-2023)
7.10.5 Amniotic Key News & Latest Developments
7.11 Nuwacell
7.11.1 Nuwacell Company Summary
7.11.2 Nuwacell Business Overview
7.11.3 Nuwacell Mesenchymal Stem Cell (MSC) Therapy Major Product Offerings
7.11.4 Nuwacell Mesenchymal Stem Cell (MSC) Therapy Revenue in Global Market (2018-2023)
7.11.5 Nuwacell Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
Table 1. Mesenchymal Stem Cell (MSC) Therapy Market Opportunities & Trends in Global Market
Table 2. Mesenchymal Stem Cell (MSC) Therapy Market Drivers in Global Market
Table 3. Mesenchymal Stem Cell (MSC) Therapy Market Restraints in Global Market
Table 4. Key Players of Mesenchymal Stem Cell (MSC) Therapy in Global Market
Table 5. Top Mesenchymal Stem Cell (MSC) Therapy Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Mesenchymal Stem Cell (MSC) Therapy Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Mesenchymal Stem Cell (MSC) Therapy Revenue Share by Companies, 2018-2023
Table 8. Global Companies Mesenchymal Stem Cell (MSC) Therapy Product Type
Table 9. List of Global Tier 1 Mesenchymal Stem Cell (MSC) Therapy Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Mesenchymal Stem Cell (MSC) Therapy Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Mesenchymal Stem Cell (MSC) Therapy Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Mesenchymal Stem Cell (MSC) Therapy Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Mesenchymal Stem Cell (MSC) Therapy Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application – Global Mesenchymal Stem Cell (MSC) Therapy Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Mesenchymal Stem Cell (MSC) Therapy Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Mesenchymal Stem Cell (MSC) Therapy Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region – Global Mesenchymal Stem Cell (MSC) Therapy Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Mesenchymal Stem Cell (MSC) Therapy Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Mesenchymal Stem Cell (MSC) Therapy Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Mesenchymal Stem Cell (MSC) Therapy Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Mesenchymal Stem Cell (MSC) Therapy Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Mesenchymal Stem Cell (MSC) Therapy Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Mesenchymal Stem Cell (MSC) Therapy Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Mesenchymal Stem Cell (MSC) Therapy Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Mesenchymal Stem Cell (MSC) Therapy Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Mesenchymal Stem Cell (MSC) Therapy Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Mesenchymal Stem Cell (MSC) Therapy Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Mesenchymal Stem Cell (MSC) Therapy Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Mesenchymal Stem Cell (MSC) Therapy Revenue, (US$, Mn), 2024-2029
Table 30. TotiCell Company Summary
Table 31. TotiCell Mesenchymal Stem Cell (MSC) Therapy Product Offerings
Table 32. TotiCell Mesenchymal Stem Cell (MSC) Therapy Revenue (US$, Mn) & (2018-2023)
Table 33. TotiCell Key News & Latest Developments
Table 34. Celltex Company Summary
Table 35. Celltex Mesenchymal Stem Cell (MSC) Therapy Product Offerings
Table 36. Celltex Mesenchymal Stem Cell (MSC) Therapy Revenue (US$, Mn) & (2018-2023)
Table 37. Celltex Key News & Latest Developments
Table 38. InGeneron Company Summary
Table 39. InGeneron Mesenchymal Stem Cell (MSC) Therapy Product Offerings
Table 40. InGeneron Mesenchymal Stem Cell (MSC) Therapy Revenue (US$, Mn) & (2018-2023)
Table 41. InGeneron Key News & Latest Developments
Table 42. Stempeutics Bangalore Company Summary
Table 43. Stempeutics Bangalore Mesenchymal Stem Cell (MSC) Therapy Product Offerings
Table 44. Stempeutics Bangalore Mesenchymal Stem Cell (MSC) Therapy Revenue (US$, Mn) & (2018-2023)
Table 45. Stempeutics Bangalore Key News & Latest Developments
Table 46. PuREC Company Summary
Table 47. PuREC Mesenchymal Stem Cell (MSC) Therapy Product Offerings
Table 48. PuREC Mesenchymal Stem Cell (MSC) Therapy Revenue (US$, Mn) & (2018-2023)
Table 49. PuREC Key News & Latest Developments
Table 50. Corestem Company Summary
Table 51. Corestem Mesenchymal Stem Cell (MSC) Therapy Product Offerings
Table 52. Corestem Mesenchymal Stem Cell (MSC) Therapy Revenue (US$, Mn) & (2018-2023)
Table 53. Corestem Key News & Latest Developments
Table 54. Sartorius Company Summary
Table 55. Sartorius Mesenchymal Stem Cell (MSC) Therapy Product Offerings
Table 56. Sartorius Mesenchymal Stem Cell (MSC) Therapy Revenue (US$, Mn) & (2018-2023)
Table 57. Sartorius Key News & Latest Developments
Table 58. StemcellX Company Summary
Table 59. StemcellX Mesenchymal Stem Cell (MSC) Therapy Product Offerings
Table 60. StemcellX Mesenchymal Stem Cell (MSC) Therapy Revenue (US$, Mn) & (2018-2023)
Table 61. StemcellX Key News & Latest Developments
Table 62. Cynata Company Summary
Table 63. Cynata Mesenchymal Stem Cell (MSC) Therapy Product Offerings
Table 64. Cynata Mesenchymal Stem Cell (MSC) Therapy Revenue (US$, Mn) & (2018-2023)
Table 65. Cynata Key News & Latest Developments
Table 66. Amniotic Company Summary
Table 67. Amniotic Mesenchymal Stem Cell (MSC) Therapy Product Offerings
Table 68. Amniotic Mesenchymal Stem Cell (MSC) Therapy Revenue (US$, Mn) & (2018-2023)
Table 69. Amniotic Key News & Latest Developments
Table 70. Nuwacell Company Summary
Table 71. Nuwacell Mesenchymal Stem Cell (MSC) Therapy Product Offerings
Table 72. Nuwacell Mesenchymal Stem Cell (MSC) Therapy Revenue (US$, Mn) & (2018-2023)
Table 73. Nuwacell Key News & Latest Developments
List of Figures
Figure 1. Mesenchymal Stem Cell (MSC) Therapy Segment by Type in 2022
Figure 2. Mesenchymal Stem Cell (MSC) Therapy Segment by Application in 2022
Figure 3. Global Mesenchymal Stem Cell (MSC) Therapy Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Mesenchymal Stem Cell (MSC) Therapy Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Mesenchymal Stem Cell (MSC) Therapy Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Mesenchymal Stem Cell (MSC) Therapy Revenue in 2022
Figure 8. By Type - Global Mesenchymal Stem Cell (MSC) Therapy Revenue Market Share, 2018-2029
Figure 9. By Application - Global Mesenchymal Stem Cell (MSC) Therapy Revenue Market Share, 2018-2029
Figure 10. By Type - Global Mesenchymal Stem Cell (MSC) Therapy Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Mesenchymal Stem Cell (MSC) Therapy Revenue Market Share, 2018-2029
Figure 12. By Application - Global Mesenchymal Stem Cell (MSC) Therapy Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Mesenchymal Stem Cell (MSC) Therapy Revenue Market Share, 2018-2029
Figure 14. By Region - Global Mesenchymal Stem Cell (MSC) Therapy Revenue Market Share, 2018-2029
Figure 15. By Country - North America Mesenchymal Stem Cell (MSC) Therapy Revenue Market Share, 2018-2029
Figure 16. US Mesenchymal Stem Cell (MSC) Therapy Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Mesenchymal Stem Cell (MSC) Therapy Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Mesenchymal Stem Cell (MSC) Therapy Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Mesenchymal Stem Cell (MSC) Therapy Revenue Market Share, 2018-2029
Figure 20. Germany Mesenchymal Stem Cell (MSC) Therapy Revenue, (US$, Mn), 2018-2029
Figure 21. France Mesenchymal Stem Cell (MSC) Therapy Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Mesenchymal Stem Cell (MSC) Therapy Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Mesenchymal Stem Cell (MSC) Therapy Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Mesenchymal Stem Cell (MSC) Therapy Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Mesenchymal Stem Cell (MSC) Therapy Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Mesenchymal Stem Cell (MSC) Therapy Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Mesenchymal Stem Cell (MSC) Therapy Revenue Market Share, 2018-2029
Figure 28. China Mesenchymal Stem Cell (MSC) Therapy Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Mesenchymal Stem Cell (MSC) Therapy Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Mesenchymal Stem Cell (MSC) Therapy Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Mesenchymal Stem Cell (MSC) Therapy Revenue, (US$, Mn), 2018-2029
Figure 32. India Mesenchymal Stem Cell (MSC) Therapy Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Mesenchymal Stem Cell (MSC) Therapy Revenue Market Share, 2018-2029
Figure 34. Brazil Mesenchymal Stem Cell (MSC) Therapy Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Mesenchymal Stem Cell (MSC) Therapy Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Mesenchymal Stem Cell (MSC) Therapy Revenue Market Share, 2018-2029
Figure 37. Turkey Mesenchymal Stem Cell (MSC) Therapy Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Mesenchymal Stem Cell (MSC) Therapy Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Mesenchymal Stem Cell (MSC) Therapy Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Mesenchymal Stem Cell (MSC) Therapy Revenue, (US$, Mn), 2018-2029
Figure 41. TotiCell Mesenchymal Stem Cell (MSC) Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Celltex Mesenchymal Stem Cell (MSC) Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. InGeneron Mesenchymal Stem Cell (MSC) Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Stempeutics Bangalore Mesenchymal Stem Cell (MSC) Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. PuREC Mesenchymal Stem Cell (MSC) Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Corestem Mesenchymal Stem Cell (MSC) Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Sartorius Mesenchymal Stem Cell (MSC) Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. StemcellX Mesenchymal Stem Cell (MSC) Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Cynata Mesenchymal Stem Cell (MSC) Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Amniotic Mesenchymal Stem Cell (MSC) Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Nuwacell Mesenchymal Stem Cell (MSC) Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
| 【間葉系幹細胞（MSC）療法について】 間葉系幹細胞（MSC）療法は、近年注目を浴びている再生医療の一つであり、様々な疾患に対する治療方法として期待されています。間葉系幹細胞は、体内の多様な細胞に分化する能力を持ち、組織の修復や再生を促進する役割を果たします。この治療法は、さまざまな疾患における症状の改善や機能の回復を目指すものです。 間葉系幹細胞の定義は、特定の細胞型に分化し、さらに自己複製能を持つ未分化な細胞の一群を指します。MSCは、主に骨髄、脂肪組織、臍帯血、歯髄など、様々な組織に存在しています。これらの細胞は、特に骨や軟骨、脂肪といった結合組織において重要な役割を果たしており、炎症反応を抑える作用や免疫調整作用も持っています。 MSCの特徴として、まず挙げられるのはその多分化能です。MSCは、骨形成、軟骨形成、脂肪形成などの異なる細胞型に分化できる能力を持っています。これにより、さまざまな組織の再生が期待できるのです。また、MSCは、自己更新能力を持ち、自身を複製し続けることができるため、限りなく供給が可能です。さらに、MSCは、ほかの細胞に対しても有益な因子を分泌することが知られており、細胞間のコミュニケーションを行いながら組織の修復を助けます。 間葉系幹細胞の種類には、いくつかのサブタイプがあります。主なものとして、骨髄由来の間葉系幹細胞があり、これは最もよく研究されているタイプです。次に、脂肪組織由来の間葉系幹細胞、また臍帯血や臍帯由来のMSCも重要な供給源として注目されています。これらの細胞は、それぞれ異なる特性を持ち、用途に応じて選択されることが一般的です。 間葉系幹細胞治療の用途は幅広く、様々な疾患に対して利用されています。例えば、骨折や関節の損傷、軟骨損傷の治療など、骨や関節の再生を目指す分野では特に注目されています。また、心筋梗塞や脳卒中、糖尿病に伴う合併症など、内臓の再生にも活用されています。最近では、自己免疫疾患や神経障害の治療においてもMSCの効果が期待され、研究が進められています。 MSC治療は、さまざまな関連技術と連携して進化しています。例えば、生体材料と組み合わせて、細胞移植の効果を高める試みが行われています。これにより、細胞が生存しやすく、機能を発揮しやすい環境を提供することが可能となります。また、遺伝子工学や細胞工学の発展により、MSCの機能を強化するための手法が模索されています。遺伝子導入により、特定の因子を過剰発現させることで、細胞の再生能力を向上させることも一つのアプローチです。 さらに、臨床応用に向けた研究が進む中で、MSCの安全性や有効性を確認するための臨床試験が数多く行われています。これにより、実際の治療効果や副作用に関するエビデンスを積み重ねていくことが求められています。また、規制当局による基準やガイドラインの整備も進められ、安心して治療を受けられる環境が整いつつあります。 しかしながら、MSC療法には課題も存在します。まず、細胞の供給源に関する問題です。特に、供給元が限られている場合、高品質な細胞を大量に確保することが難しい場合があります。 また、MSCの投与方法や適切なタイミング、用量についてもまだ解明されていない部分が多く、さらなる研究が必要です。 さらに、個体差や疾患の性質により、治療効果にはバラつきが見られる可能性があります。患者ごとに異なる反応を示すこともあるため、個別化医療の観点からそれぞれの患者に最適な治療法を提供することが求められます。これに対処すべく、ビッグデータや機械学習を活用した研究が進行中であり、将来的にはより精緻な治療が可能になることが期待されています。 総じて、間葉系幹細胞療法は、再生医療の中でも特に有望な領域であり、様々な疾患に対する新しい治療法として期待されています。自らの細胞を用いることができることから、拒絶反応のリスクも低く、患者にとっての利点が多いとされています。それに伴って、科学者や医療従事者による研究と臨床応用が進められ、多くの患者に利益をもたらすことが期待されています。今後の技術革新や研究成果によって、より一層の発展が期待される分野であると言えるでしょう。 |
